Evidence map›Paper›PMID 35892133›Full record

ArticleBMB reports2022

Erratum to: Human umbilical cord mesenchymal stem cell-derived mitochondria (PN-101) attenuate LPS-induced inflammatory responses by inhibiting NFκB signaling pathway.

Shin-Hye Yu, Soomin Kim, Yujin Kim, Seo-Eun Lee, Jong Hyeok Park, Gayoung Cho, Jong-Cheon Ha, Hahnsun Jung, Sang-Min Lim, Kyuboem Han and 3 more

Abstract readPublished Erratum
In one paragraph

Article in BMB reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Shin-Hye YuPaean Biotechnology Inc., Seoul 04552, Korea.
Soomin KimPaean Biotechnology Inc., Seoul 04552, Korea.
Yujin KimPaean Biotechnology Inc., Seoul 04552, Korea.
Seo-Eun LeePaean Biotechnology Inc., Seoul 04552, Korea.
Jong Hyeok ParkPaean Biotechnology Inc., Seoul 04552, Korea.
Gayoung ChoPaean Biotechnology Inc., Seoul 04552, Korea.
Jong-Cheon HaPaean Biotechnology Inc., Seoul 04552, Korea.
Hahnsun JungPaean Biotechnology Inc., Seoul 04552, Korea.
Sang-Min LimPaean Biotechnology Inc., Seoul 04552, Korea.
Kyuboem HanPaean Biotechnology Inc., Seoul 04552, Korea.
Hong Kyu LeePaean Biotechnology Inc., Seoul 04552, Korea.
Young Cheol KangPaean Biotechnology Inc., Seoul 04552, Korea.
Chun-Hyung KimPaean Biotechnology Inc., Seoul 04552, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[Erratum to: BMB Reports 2022; 55(3): 136-141, PMID: 34488927, PMCID: PMC8972135] The BMB Reports would like to correct in BMB Rep. 55(3):136-141, titled "Human umbilical cord mesenchymal stem cell-derived mitochondria (PN-101) attenuate LPS-induced inflammatory responses by inhibiting NFκB signaling pathway". This research was supported by NRF-2016R1A2B4007640 grant (to C-H Kim). Since grant number is incorrect, this information has now been corrected as follows: We would like to thank various Paean Biotechnology Inc. members who participated in the project. This work was supported by NRF-2018M3A9B5023055 grant (to C-H Kim). The authors apologize for any inconvenience or confusion that may be caused by this error. The ACKNOWLEDGEMENTS of Original PDF version have been corrected.

Identifiers

PMID35892133
PMCPMC9340083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.